Truist Securities adjusted its price target for American Healthcare REIT (NYSE: AHR) downward slightly, while affirming a Buy rating. The move comes as the firm reassesses its outlook for the broader REIT sector heading into 2026.
Box, Inc. strengthens its enterprise cloud offerings with the general release of Box Extract, an AI-driven data intelligence tool. The launch coincides with bullish analyst sentiment, including a Citi price target suggesting significant upside.
Lean hog futures slipped lower on Friday, contrasting with a steady rise in the CME Lean Hog Index, as traders weighed softer cash prices against stronger wholesale pork values.
In a striking pivot, crypto giant Tether is now stockpiling over a ton of gold weekly in a fortified Swiss vault—a move echoing crypto's early days but signaling a profound shift towards traditional safe-havens as digital assets falter.
While low-volatility stocks offer a haven in turbulent markets, their perceived safety can sometimes obscure underlying financial weaknesses. We examine three such stocks where calm trading patterns may not justify their current valuations or growth prospects.
As Appen announces a key governance change, its surging share price collides with deep long-term losses, forcing a hard look at whether this AI data play is a turnaround story or a value trap.
Analyst sell ratings are rare on Wall Street, making them noteworthy when they appear. We examine one such case where pessimism may have gone too far, creating a potential opportunity, alongside two stocks where the cautious outlook appears justified.
With Spirit Airlines shrinking operations under bankruptcy protection, JetBlue executives confirm detailed contingency plans are ready to deploy, centering on the crucial Fort Lauderdale hub.
Shares of major video game companies plunged Friday after Google unveiled a groundbreaking AI model capable of generating interactive worlds from simple prompts, sparking investor fears of industry disruption.
Market sentiment on prediction platform Myriad has turned bearish for the first time in two months, with traders placing nearly equal odds on Bitcoin's plunge to $69,000 or a rally to $100,000 as U.S. political uncertainty fuels extreme volatility.
Analyst firm Compass Point reiterates its Buy rating on Invesco Mortgage Capital Inc. (IVR), increasing its price target to $9.50, citing attractive mortgage spreads as a key catalyst for the REIT's potential book value growth.
LPL Financial reports retaining over 80% of Commonwealth Financial Network's advisor assets, with the staying advisors described as larger, faster-growing teams. Executives express confidence in hitting long-term retention goals as integration continues.
American Express reported a 10.6% year-over-year revenue increase to $17.57 billion for the fourth quarter of 2025, yet missed Wall Street's sales expectations. Earnings per share of $3.53 met analyst consensus estimates.
In its Q4 2025 letter, David Einhorn's Greenlight Capital revealed a new position in Antero Resources (AR), signaling a strategic move into the natural gas sector. The hedge fund's portfolio returned 8.5% for the quarter, outpacing the S&P 500.
Needham analyst Laura Martin reaffirms a Buy rating on FuboTV with a $4.25 price target, highlighting the company's strategic position as a leading live TV streaming platform amid a broader shift from traditional cable.
Despite recent market turbulence, a surge in eurozone business confidence is spotlighting companies where high insider ownership aligns management with shareholder interests. We examine three such firms poised for growth.
Linde plc (LIN) shares have shown consistent upward momentum, closing recently at $455. While short-term performance is strong, a deeper valuation analysis reveals a complex picture, with divergent views on whether the stock is a bargain or fully priced.
The Centers for Medicare & Medicaid Services (CMS) has unveiled a proposed payment update for Medicare Advantage plans that falls below industry expectations, coupled with stricter risk-adjustment regulations. This dual challenge pressures insurers like Oscar Health (NYSE: OSCR), whose tech-driven model is now under the microscope as profitability margins face a squeeze.
Summit Therapeutics (SMMT) finds itself at a crossroads, with its stock down over 30% in the past year. Conflicting signals from valuation models paint a complex picture: is the biotech firm dramatically overvalued on traditional metrics, or deeply undervalued based on future cash flows?
Initial unemployment filings in Pennsylvania fell last week, contributing to a stable national picture, though sharp swings in other states highlight ongoing regional volatility.
